WHO ICTRP trial
Clinical application of contrast-enhanced ultrasound (SonoVue) in the diagnosis…
ChiCTR2200056138 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200056138 |
|---|---|
| Public title | Clinical application of contrast-enhanced ultrasound (SonoVue) in the diagnosis and treatment of thyroid cancer after surgery |
| Scientific title | Clinical application of contrast-enhanced ultrasound (SonoVue) in the diagnosis and treatment of thyroid cancer after surgery |
| Primary sponsor | The Second Hospital of Shandong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | thyroid cancer |
| Interventions | Lymph node metastasis group:;Non-lymph node metastasis group: |
| Registration date | Feb 1, 2022 |
| Target size | Lymph node metastasis group:100;Non-lymph node metastasis group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: